Ugandan Firm Seeks $130M for Cancer Drugs After Halting COVID Vaccine Project
The founder of Dei BioPharma has announced the company is seeking $130 million from investors to complete a $1.1 billion investment plan for manufacturing key drugs for non-communicable diseases like cancer, heart disease, and acute kidney failure. Speaking to delegates from the Africa Center for Disease Control (Africa CDC) at the company’s 150-acre facility, founder…
